Risk factors for venous thromboembolism after lung transplantation

被引:50
作者
Yegen, Hilary A.
Lederer, David J.
Barr, R. Graham
Wilt, Jessie S.
Fang, Yixin
Bagiella, Emilia
D'Ovidio, Frank
Okun, Jeffrey M.
Sonett, Joshua R.
Arcasoy, Selint M.
Kawut, Steven M.
机构
[1] Columbia Univ Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, Dept Med, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Surg, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Grad Sch Arts & Sci, Dept Stat, New York, NY 10032 USA
[4] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA
关键词
long transplantation; pulmonary embolism; venous thrombosis;
D O I
10.1378/chest.07-0035
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The risk factors for venous thromboembolism (VTE) following lung transplantation are not well established. We aimed to estimate the incidence of VTE and to identify the risk factors for VTE after lung transplantation. Methods: We performed a nested case-control study within the cohort of 121 patients who underwent lung transplantation at our center between August 2001 and July 2005. Control subjects were matched to case patients on the number, of days from the time of transplant. Cox proportional hazards models were used to identify risk factors for VTE. Results: Twenty-four patients had deep vein thromboses, and 6 patients had pulmonary emboli (3 patients had both) [22% of the cohort]. In multivariate models, older age (p < 0.05), diabetes mellitus (p = 0.03), and pneumonia (p = 0.02) were associated with a higher rate of VTE. Conclusions: VTE is a frequent complication of lung transplantation. Older age, diabetes, and pneumonia increase the rate of VTE. Future studies of intensive VTE prophylaxis may be warranted.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 43 条
[11]   Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation [J].
Christie, JD ;
Carby, M ;
Bag, R ;
Corris, P ;
Hertz, M ;
Weill, D .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (10) :1454-1459
[12]   Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism - The PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study [J].
Decousus, H ;
Barral, FG ;
Buchmuller-Cordier, A ;
Charbonnier, B ;
Girard, P ;
Lamer, C ;
Laporte, A ;
Leizorovicz, A ;
Mismetti, P ;
Parent, F ;
Quenet, S ;
Rivron-Guillot, K ;
Tardy, B .
CIRCULATION, 2005, 112 (03) :416-422
[13]   Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a metaanalysis of the randomised trials [J].
Eikelboom, JW ;
Quinlan, DJ ;
Douketis, JD .
LANCET, 2001, 358 (9275) :9-15
[14]   The interactions between inflammation and coagulation [J].
Esmon, CT .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (04) :417-430
[15]   Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria [J].
Estenne, M ;
Maurer, JR ;
Boehler, A ;
Egan, JJ ;
Frost, A ;
Hertz, M ;
Mallory, GB ;
Snell, GI ;
Yousem, S .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (03) :297-310
[16]   Prevention of venous thromboembolism [J].
Geerts, WH ;
Pineo, GF ;
Heit, JA ;
Bergqvist, D ;
Lassen, MR ;
Colwell, CW ;
Ray, JG .
CHEST, 2004, 126 (03) :338S-400S
[17]   Postmenopausal hormone therapy increases risk for venous thromboembolic disease - The heart and estrogen/progestin replacement study [J].
Grady, D ;
Wenger, NK ;
Herrington, D ;
Khan, S ;
Furberg, C ;
Hunninghake, D ;
Vittinghoff, E ;
Hulley, S .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) :689-+
[18]  
Grignani G, 2000, HAEMATOLOGICA, V85, P967
[19]   Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study [J].
Heit, JA ;
Silverstein, MD ;
Mohr, DN ;
Petterson, TM ;
O'Fallon, WM ;
Melton, LJ .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (06) :809-815
[20]  
HORATTAS MC, 1988, SURGERY, V104, P561